Panupong Chaowanasawat is an Associate at the Health Intervention and Technology Assessment Program (HITAP). He holds a Bachelor of Science in Public Health (Honors) with a minor in Global Health and Social Medicine from Wayne State University, USA. His academic and professional background reflects a strong commitment to public health research and

Chayapat Rachatan is currently a Project Associate at HITAP. She supports the HTA and health system research. Her research studies focus on COVID-19 policy research and decision support, effectiveness evaluation of COVID-19 vaccine chatbot, cost analysis of governance system in health sector, situational analysis of infectious disease modelling in

Budsadee Soboon position research assistant. She graduated a bachelor’s degree in clinical pharmacy from Srinakharinwirot University, with passion to search for information, analyze the data and are interested in assessing the cost-effectiveness of medicine selection for patients. She hopes to apply her knowledge and over 12 years of experience in

Aim and objectives: This research aims to improve uptake of the Thailand National Quitline (TNQ) smoking cessation service and smoking cessation rates among Thai smokers. The objective of this study is to test whether text messages improves uptake of TNQ smoking cessation service and smoking cessation rates and to test which combination of text me

Priority setting decisions in health policy are unavoidable. Priority setting has inevitable consequences in terms of foregone health benefits. Decisions can be optimized by ensuring that decision makers have clarity about both the costs and benefits of different options. The use of economic evaluation methods can provide a systematic approach to r

HITAP, under the leadership of the National Health Foundation (NHF), Thailand, is partnering with the Saw Swee Hock School of Public Health (SSHSPH), National University of Singapore (NUS) and the Mathematical/Economic Modelling Department (MAEMOD) at the Mahidol Oxford Tropical Medicine Research Unit (MORU) as part of the Asia HTA Consortium

Infectious disease modelling have played a defining role in managing the COVID-19 pandemic and their use is expected to rise owing to emerging disease outbreaks. Hence, countries have recognised the need to strengthen the capacity to use such models to prepare, manage, and exit outbreaks by answering difficult and dynamic policy questions.   The

Together with the Mahidol Oxford Tropical Medicine Research Unit (MORU), HITAP has been engaged in assisting with building technical capacity for HTA and more broadly, evidence-informed decisions for health care in Laos since 2019. Towards this objective, HITAP hosted researchers from University of Health Sciences (UHS) and Lao-Oxford-Mahosot Hospi

We want to hear from you! Based on the description of the Lancet Commission below, please share your inputs on the key issues, challenges or opportunities that should be considered. CLICK HERE TO JOIN OUR SURVEY or scan the QR code in the following image.----------Epidemiological modelling is an important tool to help public health planners under